Helix BioPharma Corp. to Present at the BIO CEO & Investor Conference in New York
TORONTO, ON--(Marketwired - Feb 2, 2017) - Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a clinical stage immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, will be presenting at the BIO CEO …